These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 630933)

  • 1. Human alveolar macrophage proteolytic enzyme activities in chronic obstructive pulmonary disease. Lack of correlation with functional abnormalities.
    Coudon WL; Harris JO
    Chest; 1978 Mar; 73(3):364-70. PubMed ID: 630933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of proteolytic enzyme activity in pulmonary alveolar macrophages and blood leukocytes in smokers and nonsmokers.
    Harris JO; Olsen GN; Castle JR; Maloney AS
    Am Rev Respir Dis; 1975 May; 111(5):579-86. PubMed ID: 1130751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in alveolar macrophage enzyme content and activity in smokers and patients with chronic obstructive lung disease.
    Terpstra GK; De Weger RA; Wassink GA; Kreuknit J; Huidekoper HJ
    Int J Clin Pharmacol Res; 1987; 7(4):273-7. PubMed ID: 3596869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteases and protease inhibitors in chronic obstructive lung disease.
    Erikson S
    Acta Med Scand; 1978; 203(6):449-55. PubMed ID: 78661
    [No Abstract]   [Full Text] [Related]  

  • 5. Elastase release from human alveolar macrophages: comparison between smokers and nonsmokers.
    Rodriguez RJ; White RR; Senior RM; Levine EA
    Science; 1977 Oct; 198(4314):313-4. PubMed ID: 910131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxic injury to human alveolar macrophages accelerates release of previously bound neutrophil elastase. Implications for lung connective tissue injury including pulmonary emphysema.
    Campbell EJ; Wald MS
    Am Rev Respir Dis; 1983 May; 127(5):631-5. PubMed ID: 6342481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelationships between the human alveolar macrophage and alpha-1-antitrypsin.
    Cohen AB
    J Clin Invest; 1973 Nov; 52(11):2793-9. PubMed ID: 4201266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elastolytic activity of alveolar macrophages in chronic bronchitis: comparison of current and former smokers.
    O'Neill S; Prichard JS
    Thorax; 1983 May; 38(5):356-9. PubMed ID: 6554022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in enzyme content and activity of alveolar macrophages in smokers and COLD patients.
    Huidekoper HJ; Kreukniet J; Terpstra GK; Wassink GA; de Weger RA
    Eur J Respir Dis Suppl; 1986; 146():195-201. PubMed ID: 3465547
    [No Abstract]   [Full Text] [Related]  

  • 10. Alpha1-antitrypsin deficiency (second of two parts).
    Morse JO
    N Engl J Med; 1978 Nov; 299(20):1099-105. PubMed ID: 360065
    [No Abstract]   [Full Text] [Related]  

  • 11. The release of elastase, myeloperoxidase, and lysozyme from human alveolar macrophages.
    Cohen AB; Chenoweth DE; Hugli TE
    Am Rev Respir Dis; 1982 Aug; 126(2):241-7. PubMed ID: 6285785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
    Abboud RT; Vimalanathan S
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelationships between neutrophil elastase, serum alpha, -antitrypsin, lung function and chest radiography in patients with chronic airflow obstruction.
    Abboud RT; Rushton JM; Grzybowski S
    Am Rev Respir Dis; 1979 Jul; 120(1):31-40. PubMed ID: 313728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fate of neutrophil elastase incorporated by human alveolar macrophages.
    McGowan SE; Stone PJ; Calore JD; Snider GL; Franzblau C
    Am Rev Respir Dis; 1983 Apr; 127(4):449-55. PubMed ID: 6551160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunolocalization of elastase in human emphysematous lungs.
    Damiano VV; Tsang A; Kucich U; Abrams WR; Rosenbloom J; Kimbel P; Fallahnejad M; Weinbaum G
    J Clin Invest; 1986 Aug; 78(2):482-93. PubMed ID: 3525610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteases and lung injury. A state-of-the-art minireview.
    Janoff A
    Chest; 1983 May; 83(5 Suppl):54S-58S. PubMed ID: 6340986
    [No Abstract]   [Full Text] [Related]  

  • 17. The pulmonary-alveolar macrophage (second of two parts).
    Hocking WG; Golde DW
    N Engl J Med; 1979 Sep; 301(12):639-45. PubMed ID: 381928
    [No Abstract]   [Full Text] [Related]  

  • 18. Human alveolar macrophage and obstructive lung disease.
    Gee JB; Hinman L; Stevens C; Matthay R
    Chest; 1980 Feb; 77(2 Suppl):271-2. PubMed ID: 6898474
    [No Abstract]   [Full Text] [Related]  

  • 19. [Endogenous factors in the development of emphysema].
    Junod AF
    Schweiz Med Wochenschr; 1978 Feb; 108(8):260-2. PubMed ID: 625643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of alveolar macrophage plasminogen activator and elastase activities to lung function and CT evidence of emphysema.
    Abboud RT; Ofulue AF; Sansores RH; Muller NL
    Chest; 1998 May; 113(5):1257-63. PubMed ID: 9596303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.